Community-based smoking cessation program for adults with high stress sensitivity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a personalized smoking cessation intervention tailored for adults with high anxiety sensitivity. Participants will receive counseling and nicotine replacement therapy, and will be randomly assigned to either a high-intensity or low-intensity exercise program to enhance smoking cessation outcomes. The intervention is designed to be implemented in community settings, specifically through YMCA facilities, targeting racially and ethnically diverse populations. The study will assess whether this approach can improve smoking cessation rates among individuals who are particularly sensitive to anxiety.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult (age ≥ 18);
* High Anxiety Sensitivity (≥5 on the Short Scale Anxiety Sensitivity Index \[SSASI\]);
* Daily smoker, ≥5 cigarettes (including e-cigarettes, little cigars/cigarillos) for ≥1 year;
* Motivated to quit smoking as evidenced by a score of ≥5 on a 0-10 Likert scale;
* Body mass index \< 40;
* Medical clearance to participate.
* Located near a participating YMCA site (within 50 miles)

Exclusion Criteria:

* Regular exercise defined as engaging in vigorous-intensity exercise for at least 75 minutes per week for the last 3 months
* Receiving current intervention for smoking cessation.
* Outstanding debt to the YMCA
* Listed as a sex offender on the National Sex Offender Registry

Where it's running

• University of Texas at Austin
  Austin, Texas, United States Recruiting

Study contacts

• Principal investigator: Jasper Smits, PhD — University of Texas at Austin
• Study coordinator: Marla I Sarmiento, BS
• Email: sarmimar@utexas.edu
• Phone: 915-502-9979

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel

  This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.

  Recruiting at 2 sites American University of Beirut Medical Center · Beirut, Beirut and 1 other locations · NCT07712887

• Do a single nicotine pouch affect cigarette craving and brain response to smoking cues

  This study tests whether a single 6 mg oral nicotine pouch can reduce craving and alter prefrontal brain responses to smoking cues in adults who smoke cigarettes.

  Recruiting University of Southern California · Los Angeles, California · NCT07698470

• TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping

  This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.

  Recruiting University of Zurich · Zurich · NCT07568483

• Social media support groups to help teens and young adults quit vaping

  This pilot tries a social-media group program called the Quit the Hit Toolkit to help adolescents and young adults who vape stop using nicotine.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07540780

• Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients

  This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.

  Recruiting TsaoTun Psychiatric Center, Department of Health, Taiwan · Nantou City · NCT07466875

• Sex differences in how menthol e-cigarettes appeal to people who smoke

  This study tests whether men and women differ in how menthol e-cigarettes with or without nicotine appeal to smokers who have used e-cigarettes before.

  Recruiting Yale University · New Haven, Connecticut · NCT07398976

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.